A phase III, randomized, controlled, observer-blind, multicenter study to evaluate the immunogenicity, safety and tolerability of two doses of FLUAD-H5N1 influenza vaccine in adult and elderly subjects

Trial Profile

A phase III, randomized, controlled, observer-blind, multicenter study to evaluate the immunogenicity, safety and tolerability of two doses of FLUAD-H5N1 influenza vaccine in adult and elderly subjects

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Influenza A virus vaccine-H5N1; Influenza virus vaccine
  • Indications Influenza A virus H5N1 subtype; Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 06 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top